Healthcare101

  The   Global Leukapheresis Products Market   was estimated to be worth USD 70 million in 2023 and is poised to reach USD 100 million by 2028, growing at a CAGR of 8.3%. The global leukopaks market was estimated to be worth USD 200 million in 2023 and is poised to reach USD 1020 million by 2028, growing at a CAGR of 38.1%. One of the key trends in the leukopaks market is the increasing use of leukopaks in CAR T-cell therapy. CAR T-cell therapy is a type of immunotherapy that uses the patient's own immune cells to fight cancer. It is a promising new treatment for leukemia and other blood cancers. Leukopaks are used to collect the patient's immune cells, which are then modified to fight cancer. Other trends in the leukopaks market include the increasing demand for leukopaks in personalized medicine and the development of new leukopak collection and storage methods. Attractive Opportunities in the Leukapheresis Products Market Download PDF Brochure: https://www.marketsandmarkets.

  The   Global Blood Screening Market   in terms of revenue was estimated to be worth $2.4 billion in 2023 and is poised to reach $3.4 billion by 2028, growing at a CAGR of 7.2% from 2023 to 2028. The new research study consists of an industry trend analysis of the market. The new research study consists of industry trends, pricing analysis, patent analysis, conference and webinar materials, key stakeholders, and buying behaviour in the market. The need for blood is ever-increasing, forcing the number of blood donations to rise as well throughout the world. Combining this factor along with the growing infectious diseases is the major contributor for the growing blood screening market. On the other hand, the unfavorable reimbursement scenario and the high cost of instruments and kits may restrain the growth of this market to a certain extent. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=267747042 Blood screening Market Dynamics Driver: Increasing number

  X-Ray Detectors Market   size is projected to reach USD 4.0 billion by 2027 from USD 3.1 billion in 2022, at a CAGR of 5.2% according to a new report by MarketsandMarkets™. Increasing investments in advancing healthcare facilities & digital imaging technologies, growing demand for early diagnosis, and widening scope of clinical applications of X-ray detectors, rising chronic disorders which need quick examinations and increasing sedentary lifestyles are some of the key factors driving market growth. Global X-Ray Detector Market Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=7004984 Browse in-depth TOC on "X-Ray Detectors Market" 224 - Tables 39 - Figures 245 – Pages Body Contouring segment to register significant growth rate over the forecast period of 2022-2027 Based on the product type, the global X-Ray detector market is segmented into Flat Panel Detectors, Computed Radiography detectors, Line-Scan detectors, and Charged Coupled detect

  Cell Analysis Market   in terms of revenue was estimated to be worth $20.2 billion in 2023 and is poised to reach $33.9 billion by 2028, growing at a CAGR of 10.9% from 2023 to 2028 according to a new report by MarketsandMarkets™. Rising preference for cell-based assays in drug discovery serves as one of the key driving factors of the cell analysis market. Pharmaceutical & biotechnology companies and CROs are replacing biochemical assays with cell-based assays for their lead identification and optimization processes in drug discovery. This is attributive to the several advantages over in vitro biochemical assays. They offer consistent tissue-specific responses in a biologically relevant microenvironment as opposed to biochemical assays. Attractive Opportunities in the Cell Analysis Market Download an Illustrative overview: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946 Browse in-depth TOC on "Cell Analysis Market" 233 - Tables 39 - Figures 250 – Pages

  The   Metabolism Assays Market   is projected to reach USD 2.1 billion by 2028 from USD 1.4 billion in 2023, at a CAGR of 7.8% during the forecast period. The growth in this market is attributed to the growing prevalence of diabetes, the global increase in the number of hospitals, and the high rate of obese population. However, alternative methods or techniques restrain the growth of this market. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=135163479 Global Metabolism Assays Dynamics DRIVER: Increasing funding and investments in metabolic research Metabolic research funding and investments are crucial for advancing the metabolic processes understanding, producing new metabolic disease treatments, and improving public health. Diseases like diabetes, obesity, lipid metabolism, mitochondrial disorders, and metabolic pathways are being considered as metabolic diseases. Various sources, including government agencies, private foundations, pharmaceutical co

  Humanized Mouse and Rat Model Market   in terms of revenue was estimated to be worth $259 million in 2023 and is poised to reach $349 million by 2028, growing at a CAGR of 6.2% from 2023 to 2028 according to a new report by MarketsandMarkets™. Rising demand for personalized medicine is one of the prominent driving factor of the humanized mouse and rat model market. Existing mouse models have certain limitations in predictive research, unable to effectively gauge response in human cancer patients. Therefore, research institutes and academic institutes are focused on the development of advanced innovative models. Demand for personalized medicine is further driven by advancements in proteomics, genomics, and metabolomics. Additionally demand for targeted diagnostics and preventive medicine are propelling the demand for humanized mouse and rat research models. Attractive Opportunities in humanized mouse and rat model Market Download an Illustrative overview: https://www.marketsandmarkets

According to the new market research report published by MarketsandMarkets, " Point of Care Diagnostics Market by Product (Glucose, HIV, Hepatitis C, Pregnancy), Platform (Microfluidics, Dipstick, Immunoassay), Purchase(OTC, Prescription), Sample(Blood, Urine), User (Pharmacy, Hospital, Homecare) - Global Forecast to 2027", the global point of care diagnostics market in terms of revenue was estimated to be worth $45.4 billion in 2022 and is poised to reach $75.5 billion by 2027, growing at a CAGR of 10.7% from 2022 to 2027. Browse in-depth TOC on "Point of Care Diagnostics Industry" 334 - Tables 48 - Figures 398 – Pages. Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=106829185 The high prevalence of diabetes, cardiovascular diseases, infectious diseases and other target conditions, the increased number of CLIA-waived POC tests, increased focus of players in strengthening the POCT product portfolio, initiatives by governme